TAK-243

A Phase 1 Study of TAK-243 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

Near Add Your Location

Sorting 3 by

Northwestern University
Feinberg School of Medicine
Chicago, IL
  • Accepting patients
Massey Cancer Center
Virginia Commonwealth University (VCU Health)
Richmond, VA
  • Accepting patients

Center of Excellence

Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.